Article
Intracerebroventricular administration of Cystatin C ameliorates disease in SOD1-linked amyotrophic lateral sclerosis mice.
Journal of neurochemistry - 1 Apr 2018
Watanabe Seiji, Komine Okiru, Endo Fumito, Wakasugi Keisuke, Yamanaka Koji
Abstract excerpt
Cystatin C (CysC) is a major protein component of Bunina bodies, which are a pathological hallmark observed in the remaining motor neurons of patients with amyotrophic lateral sclerosis (ALS). Dominant mutations in the SOD1 gene, encoding Cu/Zn superoxide dismutase (SOD1), are causative for a subset of inherited ALS cases. Our previous study showed that CysC exerts a neuroprotective effect against mutant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
